If I remember correctly, I was – some 20 years ago – a founding member of the editorial board of the journal Evidence-Based Complementary and Alternative Medicine (EBCAM). I also published several papers there, but eventually I became concerned about what seemed to be going on at the journal (it seemed a money-making scam to me) and withdrew my cooperation. Since then, I have repeatedly posted on this blog about this strange journal, e.g.:
- EBCAM: an alt med journal that puzzles me a great deal
- Some alternative medicine journals should be de-listed
- Fraud and greed can cause enormous harm
Yesterday,I came across this announcement by John Wiley & Sons, now the publisher of EBCAM:
Evidence-Based Complementary and Alternative Medicine ceased publishing as of September 2024.
Trying to find out more about this surprising action, I found this little note:
John Wiley & Sons, a global publication house with revenues north of $2 billion, announced on May 19, 2024, that it was closing 19 journals it acquired as part of its 2021 purchase of Egypt-based Hindawi publishing company, citing large-scale research fraud.
Next, I went on to Medline and saw that EBCAM had to retract 744 (!) of its papers.
That amount of retractions must be a world record!
I thus understand that the journal was no longer tenable. But what exactly did happen? What brought about the decision to cease publication?
I have no idea (various searches for answers were unsuccessful) and would be most grateful, if someone in the know could fill me in.
In the Bit-Kitchen helping hands added some beef:
“World record: EBCAM had to retract 1497 of its papers”
https://www.allaxys.com/~kanzlerzwo/index.php?topic=13421.0
xhttps://www.allaxys.com/~aktenschrank/frauds/1497_PAPERS_RETRACTED_800.png
xhttps://www.allaxys.com/~aktenschrank/frauds/RETRACTIONS_WILEY_OCTOBER_2024_700.jpg
In 2023 SEVENTYFOUR PERCENT of the articles were retracted. 2022 and 2021 already were setting record heights.
Looks like a lot of Chinese now have to find an other place for their forgeries.